After tracking data for nearly 800 professional athletes, the researchers found that no adverse cardiac events were reported after a mild or asymptomatic COVID-19 infection.
“The Ross procedure should be considered in young and middle-aged adults who need AVR and can be referred to dedicated centers with expertise in this operation,” researchers explained.
The new study, published by the American Journal of Cardiology, suggests that frailty could be a helpful predictor for major bleeding events after PCI.
The study included data from nearly 17 million adults who received treatment from 2005 to 2011. Researchers compared the stroke rates of patients with atrial fibrillation and those without it.
After two years, TAVR was still linked to a reduction in the study’s primary endpoint, but it was also associated with a greater risk of valve thrombosis.